The global Extracellular Vesicle Therapy market size is predicted to grow from US$ 884 million in 2024 to US$ 1636 million in 2030; it is expected to grow at a CAGR of 10.8% from 2024 to 2030.

Extracellular Vesicle Therapy refers to an emerging therapy that uses extracellular vesicles as a therapeutic approach. These extracellular vesicles are small vesicles released by cells that can carry a variety of biological molecules (such as proteins, lipids, and RNA) to transmit signals and exchange substances between cells.

United States market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Extracellular Vesicle Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Extracellular Vesicle Therapy players cover FUJIFILM Diosynth Biotechnologies, EV Therapeutics, Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information) newest research report, the Extracellular Vesicle Therapy Industry Forecast looks at past sales and reviews total world Extracellular Vesicle Therapy sales in 2023, providing a comprehensive analysis by region and market sector of projected Extracellular Vesicle Therapy sales for 2024 through 2030. With Extracellular Vesicle Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracellular Vesicle Therapy industry.

This Insight Report provides a comprehensive analysis of the global Extracellular Vesicle Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Extracellular Vesicle Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Extracellular Vesicle Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracellular Vesicle Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracellular Vesicle Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Extracellular Vesicle Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Exosome-based
    Microvesicle-based

Segmentation by Application:

    Cancer Treatment
    Regenerative Medicine
    Drug Delivery
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    FUJIFILM Diosynth Biotechnologies
    EV Therapeutics
    Cellular Biomedicine Group
    Codiak BioSciences
    Coya Therapeutics
    Curexsys
    Evox Therapeutics
    ExoCoBio
    ILIAS Biologics
    Rion
    SHIFTBIO